102 related articles for article (PubMed ID: 33442697)
1. Self-organized stem cell-derived human lung buds with proximo-distal patterning and novel targets of SARS-CoV-2.
Rosado-Olivieri EA; Razooky B; Hoffmann HH; De Santis R; Rice CM; Brivanlou AH
bioRxiv; 2021 Jan; ():. PubMed ID: 33442697
[TBL] [Abstract][Full Text] [Related]
2. Organotypic human lung bud microarrays identify BMP-dependent SARS-CoV-2 infection in lung cells.
Rosado-Olivieri EA; Razooky B; Le Pen J; De Santis R; Barrows D; Sabry Z; Hoffmann HH; Park J; Carroll TS; Poirier JT; Rice CM; Brivanlou AH
Stem Cell Reports; 2023 May; 18(5):1107-1122. PubMed ID: 37084725
[TBL] [Abstract][Full Text] [Related]
3. Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection.
Pei R; Feng J; Zhang Y; Sun H; Li L; Yang X; He J; Xiao S; Xiong J; Lin Y; Wen K; Zhou H; Chen J; Rong Z; Chen X
Protein Cell; 2021 Sep; 12(9):717-733. PubMed ID: 33314005
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Infection of Pluripotent Stem Cell-derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response.
Huang J; Hume AJ; Abo KM; Werder RB; Villacorta-Martin C; Alysandratos KD; Beermann ML; Simone-Roach C; Lindstrom-Vautrin J; Olejnik J; Suder EL; Bullitt E; Hinds A; Sharma A; Bosmann M; Wang R; Hawkins F; Burks EJ; Saeed M; Wilson AA; Mühlberger E; Kotton DN
bioRxiv; 2020 Aug; ():. PubMed ID: 32637964
[TBL] [Abstract][Full Text] [Related]
5. Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus.
Ekanger CT; Zhou F; Bohan D; Lotsberg ML; Ramnefjell M; Hoareau L; Røsland GV; Lu N; Aanerud M; Gärtner F; Salminen PR; Bentsen M; Halvorsen T; Ræder H; Akslen LA; Langeland N; Cox R; Maury W; Stuhr LEB; Lorens JB; Engelsen AST
Front Cell Infect Microbiol; 2022; 12():841447. PubMed ID: 35360113
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 infection of human-induced pluripotent stem cells-derived lung lineage cells evokes inflammatory and chemosensory responses by targeting mitochondrial pathways.
Surendran H; Kumar S; Narasimhaiah S; Ananthamurthy A; Varghese PS; D'Souza GA; Medigeshi G; Pal R
J Cell Physiol; 2022 Jul; 237(7):2913-2928. PubMed ID: 35460571
[TBL] [Abstract][Full Text] [Related]
7. Protease inhibitor Camostat Mesyalte blocks wild type SARS-CoV-2 and D614G viral entry in human engineered miniature lungs.
Wu T; Rabi SA; Michaud WA; Becerra D; Gilpin SE; Mino-Kenudson M; Ott HC
Biomaterials; 2022 Jun; 285():121509. PubMed ID: 35533440
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium.
Sims AC; Burkett SE; Yount B; Pickles RJ
Virus Res; 2008 Apr; 133(1):33-44. PubMed ID: 17451829
[TBL] [Abstract][Full Text] [Related]
9. Diesel Particulate Matter 2.5 Induces Epithelial-to-Mesenchymal Transition and Upregulation of SARS-CoV-2 Receptor during Human Pluripotent Stem Cell-Derived Alveolar Organoid Development.
Kim JH; Kim J; Kim WJ; Choi YH; Yang SR; Hong SH
Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33202948
[TBL] [Abstract][Full Text] [Related]
10. Micro-patterned culture of iPSC-derived alveolar and airway cells distinguishes SARS-CoV-2 variants.
Masui A; Hashimoto R; Matsumura Y; Yamamoto T; Nagao M; Noda T; Takayama K; Gotoh S
Stem Cell Reports; 2024 Apr; 19(4):545-561. PubMed ID: 38552631
[TBL] [Abstract][Full Text] [Related]
11. Induced pluripotent stem cell-based disease modeling and prospective immune therapy for coronavirus disease 2019.
Chakrabarty K; Shetty R; Argulwar S; Das D; Ghosh A
Cytotherapy; 2022 Mar; 24(3):235-248. PubMed ID: 34656419
[TBL] [Abstract][Full Text] [Related]
12. Human iPSC-derived alveolar and airway epithelial cells can be cultured at air-liquid interface and express SARS-CoV-2 host factors.
Abo KM; Ma L; Matte T; Huang J; Alysandratos KD; Werder RB; Mithal A; Beermann ML; Lindstrom-Vautrin J; Mostoslavsky G; Ikonomou L; Kotton DN; Hawkins F; Wilson A; Villacorta-Martin C
bioRxiv; 2020 Jun; ():. PubMed ID: 32577635
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery.
Mulay A; Konda B; Garcia G; Yao C; Beil S; Sen C; Purkayastha A; Kolls JK; Pociask DA; Pessina P; de Aja JS; Garcia-de-Alba C; Kim CF; Gomperts B; Arumugaswami V; Stripp BR
bioRxiv; 2020 Jun; ():. PubMed ID: 32637946
[TBL] [Abstract][Full Text] [Related]
14. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801.
Wahl A; Gralinski LE; Johnson CE; Yao W; Kovarova M; Dinnon KH; Liu H; Madden VJ; Krzystek HM; De C; White KK; Gully K; Schäfer A; Zaman T; Leist SR; Grant PO; Bluemling GR; Kolykhalov AA; Natchus MG; Askin FB; Painter G; Browne EP; Jones CD; Pickles RJ; Baric RS; Garcia JV
Nature; 2021 Mar; 591(7850):451-457. PubMed ID: 33561864
[TBL] [Abstract][Full Text] [Related]
16. The Human Nose Organoid Respiratory Virus Model: an
Rajan A; Weaver AM; Aloisio GM; Jelinski J; Johnson HL; Venable SF; McBride T; Aideyan L; Piedra FA; Ye X; Melicoff-Portillo E; Yerramilli MRK; Zeng XL; Mancini MA; Stossi F; Maresso AW; Kotkar SA; Estes MK; Blutt S; Avadhanula V; Piedra PA
mBio; 2021 Feb; 13(1):e0351121. PubMed ID: 35164569
[TBL] [Abstract][Full Text] [Related]
17. Single domain antibodies derived from ancient animals as broadly neutralizing agents for SARS-CoV-2 and other coronaviruses.
Lim HT; Kok BH; Lim CP; Abdul Majeed AB; Leow CY; Leow CH
Biomed Eng Adv; 2022 Dec; 4():100054. PubMed ID: 36158162
[TBL] [Abstract][Full Text] [Related]
18. iPSC-derived mesenchymal cells that support alveolar organoid development.
Tamai K; Sakai K; Yamaki H; Moriguchi K; Igura K; Maehana S; Suezawa T; Takehara K; Hagiwara M; Hirai T; Gotoh S
Cell Rep Methods; 2022 Oct; 2(10):100314. PubMed ID: 36313800
[TBL] [Abstract][Full Text] [Related]
19. Human iPSC-Based Model of COPD to Investigate Disease Mechanisms, Predict SARS-COV-2 Outcome, and Test Preventive Immunotherapy.
Dagher R; Moldobaeva A; Gubbins E; Clark S; Madel Alfajaro M; Wilen CB; Hawkins F; Qu X; Chien Chiang C; Li Y; Clarke L; Ikeda Y; Brown C; Kolbeck R; Ma Q; Rojas M; Koff JL; Ghaedi M
Stem Cells; 2024 Mar; 42(3):230-250. PubMed ID: 38183264
[TBL] [Abstract][Full Text] [Related]
20. Early protective effect of a ("pan") coronavirus vaccine (PanCoVac) in Roborovski dwarf hamsters after single-low dose intranasal administration.
Abdelaziz MO; Raftery MJ; Weihs J; Bielawski O; Edel R; Köppke J; Vladimirova D; Adler JM; Firsching T; Voß A; Gruber AD; Hummel LV; Fernandez Munoz I; Müller-Marquardt F; Willimsky G; Elleboudy NS; Trimpert J; Schönrich G
Front Immunol; 2023; 14():1166765. PubMed ID: 37520530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
